NVS SMA Drug Gets CHMP Backing, Malaria Drug Wins WHO Prequalification

Novartis secures CHMP backing for Itvisma in SMA and wins WHO nod for Coartem Baby, targeting critical gaps in rare disease and infant malaria care.